Terumo Corporation (TRUMF)
OTCMKTS
· Delayed Price · Currency is USD
17.89
-0.11 (-0.61%)
May 12, 2025, 4:00 PM EDT
Revenue by Product
Fiscal year is April - March.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| Cardiac and Vascular Company | 612.15B |
Log In |
Log In |
Log In |
Log In |
| Cardiac and Vascular Company Growth | 15.63% |
Log In |
Log In |
Log In |
Log In |
| Medical Care Solutions Company | 210.02B |
Log In |
Log In |
Log In |
Log In |
| Medical Care Solutions Company Growth | 8.53% |
Log In |
Log In |
Log In |
Log In |
| Blood and Cell Technologies Company | 188.68B |
Log In |
Log In |
Log In |
Log In |
| Blood and Cell Technologies Company Growth | 16.46% |
Log In |
Log In |
Log In |
Log In |
| Adjustments from | 289.00M |
Log In |
Log In |
Log In |
Log In |
| Adjustments from Growth | 26.20% |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| Americas | 380.35B |
Log In |
Log In |
Log In |
Log In |
| Americas Growth | 21.74% |
Log In |
Log In |
Log In |
Log In |
| Europe | 211.78B |
Log In |
Log In |
Log In |
Log In |
| Europe Growth | 17.38% |
Log In |
Log In |
Log In |
Log In |
| China | 85.81B |
Log In |
Log In |
Log In |
Log In |
| China Growth | 13.83% |
Log In |
Log In |
Log In |
Log In |
| Asia and Others | 115.91B |
Log In |
Log In |
Log In |
Log In |
| Asia and Others Growth | 7.40% |
Log In |
Log In |
Log In |
Log In |
| Japan | 217.30B |
Log In |
Log In |
Log In |
Log In |
| Japan Growth | 3.96% |
Log In |
Log In |
Log In |
Log In |
Other
Fiscal year is April - March.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| Cardiac and Vascular Company Adjusted Operating Profit | 149.78B |
Log In |
Log In |
Log In |
Log In |
| Cardiac and Vascular Company Adjusted Operating Profit Growth | 19.50% |
Log In |
Log In |
Log In |
Log In |
| Medical Care Solutions Company Adjusted Operating Profit | 23.01B |
Log In |
Log In |
Log In |
Log In |
| Medical Care Solutions Company Adjusted Operating Profit Growth | -15.67% |
Log In |
Log In |
Log In |
Log In |
| Blood and Cell Technologies Company Adjusted Operating Profit | 22.33B |
Log In |
Log In |
Log In |
Log In |
| Blood and Cell Technologies Company Adjusted Operating Profit Growth | 105.28% |
Log In |
Log In |
Log In |
Log In |
| Adjustments from Adjusted Operating Profit | 1.23B |
Log In |
Log In |
Log In |
Log In |
| Adjustments from Adjusted Operating Profit Growth | -207.14% |
Log In |
Log In |
Log In |
Log In |
| Cardiac and Vascular Company Production Result | - |
Log In |
Log In |
Log In |
Log In |
| Cardiac and Vascular Company Production Result Growth | - |
Log In |
Log In |
Log In |
Log In |
| Medical Care Solutions Company Production Result | - |
Log In |
Log In |
Log In |
Log In |
| Medical Care Solutions Company Production Result Growth | - |
Log In |
Log In |
Log In |
Log In |
| Blood and Cell Technologies Company Production Result | - |
Log In |
Log In |
Log In |
Log In |
| Blood and Cell Technologies Company Production Result Growth | - |
Log In |
Log In |
Log In |
Log In |
| Total Production Result | - |
Log In |
Log In |
Log In |
Log In |
| Total Production Result Growth | - |
Log In |
Log In |
Log In |
Log In |